Evolent Health (NYSE: EVH) reported Q1 EPS of $0.06, $0.02 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $483.65 million versus the consensus estimate of $460.58 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.